Lactate dehydrogenase as a selection criterion for ipilimumab treatment in metastatic melanoma von Kelderman, Sander, Heemskerk, Bianca, van Tinteren, Harm, van den Brom, Rob R. H., Hospers, Geke A. P., van den Eertwegh, Alfonsus J. M., Kapiteijn, Ellen W., de Groot, Jan Willem B., Soetekouw, Patricia, Jansen, Rob L., Fiets, Edward, Furness, Andrew J. S., Renn, Alexandra, Krzystanek, Marcin, Szallasi, Zoltan, Lorigan, Paul, Gore, Martin E., Schumacher, Ton N. M., Haanen, John B. A. G., Larkin, James M. G., Blank, Christian U.

Volltext

Pembrolizumab versus ipilimumab in advanced melanoma (KEYNOTE-006): post-hoc 5-year results from an open-label, multicentre, randomised, controlled, phase 3 study von Robert, Caroline, Prof, Ribas, Antoni, Prof, Schachter, Jacob, Prof, Arance, Ana, MD, Grob, Jean-Jacques, Prof, Mortier, Laurent, Prof, Daud, Adil, Prof, Carlino, Matteo S, MB, McNeil, Catriona M, MD, Lotem, Michal, Prof, Larkin, James M G, Prof, Lorigan, Paul, Prof, Neyns, Bart, Prof, Blank, Christian U, Prof, Petrella, Teresa M, MD, Hamid, Omid, MD, Su, Shu-Chih, PhD, Krepler, Clemens, MD, Ibrahim, Nageatte, MD, Long, Georgina V, Prof

Volltext

Lifileucel, a Tumor-Infiltrating Lymphocyte Therapy, in Metastatic Melanoma von Sarnaik, Amod A, Hamid, Omid, Khushalani, Nikhil I, Lewis, Karl D, Medina, Theresa, Kluger, Harriet M, Thomas, Sajeve S, Domingo-Musibay, Evidio, Pavlick, Anna C, Whitman, Eric D, Martin-Algarra, Salvador, Corrie, Pippa, Curti, Brendan D, Oláh, Judit, Lutzky, Jose, Weber, Jeffrey S, Larkin, James M G, Shi, Wen, Takamura, Toshimi, Jagasia, Madan, Qin, Harry, Wu, Xiao, Chartier, Cecile, Graf Finckenstein, Friedrich, Fardis, Maria, Kirkwood, John M, Chesney, Jason A

Volltext

Active surveillance in metastatic renal-cell carcinoma: a prospective, phase 2 trial von Rini, Brian I, Prof, Dorff, Tanya B, MD, Elson, Paul, ScD, Rodriguez, Cristina Suarez, MD, Shepard, Dale, MD, Wood, Laura, MSN, Humbert, Jordi, BSc, Pyle, Linda, RN, Wong, Yu-Ning, MD, Finke, James H, Prof, Rayman, Patricia A, MS, Larkin, James M G, FRCP, Garcia, Jorge A, MD, Plimack, Elizabeth R, MD

Volltext

Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma von Flaherty, Keith T, Robert, Caroline, Hersey, Peter, Nathan, Paul, Garbe, Claus, Milhem, Mohammed, Demidov, Lev V, Hassel, Jessica C, Rutkowski, Piotr, Mohr, Peter, Dummer, Reinhard, Trefzer, Uwe, Larkin, James M.G, Utikal, Jochen, Dreno, Brigitte, Nyakas, Marta, Middleton, Mark R, Becker, Jürgen C, Casey, Michelle, Sherman, Laurie J, Wu, Frank S, Ouellet, Daniele, Martin, Anne-Marie, Patel, Kiran, Schadendorf, Dirk

Volltext

Real-world outcomes with ipilimumab and nivolumab in advanced melanoma: a multicentre retrospective study von Serra-Bellver, Patricio, Versluis, Judith M., Oberoi, Honey K., Zhou, Cong, Slattery, Timothy D., Khan, Yasir, Patrinely, James R., Pires da Silva, Inês, Martínez-Vila, C., Cook, Natalie, Graham, Donna M., Carlino, Matteo S., Menzies, Alexander M., Arance, Ana M., Johnson, Douglas B., Long, Georgina V., Pickering, Lisa, Larkin, James M.G., Blank, Christian U., Lorigan, Paul

Volltext

Open-Label, Single-Arm Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Clear Cell Renal Cell Carcinoma von McDermott, David F, Lee, Jae-Lyun, Bjarnason, Georg A, Larkin, James M G, Gafanov, Rustem A, Kochenderfer, Mark D, Jensen, Niels Viggo, Donskov, Frede, Malik, Jahangeer, Poprach, Alexandr, Tykodi, Scott S, Alonso-Gordoa, Teresa, Cho, Daniel C, Geertsen, Poul F, Climent Duran, Miguel Angel, DiSimone, Christopher, Silverman, Rachel Kloss, Perini, Rodolfo F, Schloss, Charles, Atkins, Michael B

Volltext

Recent advances in the treatment of renal cell carcinoma and the role of targeted therapies von Chowdhury, Simon, Larkin, James M.G, Gore, Martin E

Volltext

Phase II Study Investigating the Safety and Efficacy of Savolitinib and Durvalumab in Metastatic Papillary Renal Cancer (CALYPSO) von Suárez, Cristina, Larkin, James M G, Patel, Poulam, Valderrama, Begoña P, Rodriguez-Vida, Alejo, Glen, Hilary, Thistlethwaite, Fiona, Ralph, Christy, Srinivasan, Gopalakrishnan, Mendez-Vidal, Maria Jose, Hartmaier, Ryan, Markovets, Aleksandra, Prendergast, Aaron, Szabados, Bernadett, Mousa, Kelly, Powles, Thomas

Volltext

Fatigue in Renal Cell Carcinoma: The Hidden Burden of Current Targeted Therapies von Larkin, James M.G., Pyle, Lynda M., Gore, Martin E.

Volltext

Management of poor-risk metastatic renal cell carcinoma: current approaches, the role of temsirolimus and future directions von Porta, Camillo, Tortora, Giampaolo, Larkin, James MG, Hutson, Thomas E

Volltext

Epothilones in the treatment of cancer von Larkin, James MG, Kaye, Stanley B

Volltext

Combination Systemic Therapy for Advanced Renal Cell Carcinoma von Miller, Rowan E., Larkin, James M. G.

Volltext

Kinase inhibitors in the treatment of renal cell carcinoma von Larkin, James M.G., Eisen, Tim

Volltext

Drug Insight: advances in renal cell carcinoma and the role of targeted therapies von Larkin, James MG, Chowdhury, Simon, Gore, Martin E

Volltext

melanocortin receptor agonist NDP-MSH impairs the allostimulatory function of dendritic cells von Rennalls, La'Verne P, Seidl, Thomas, Larkin, James M.G, Wellbrock, Claudia, Gore, Martin E, Eisen, Tim, Bruno, Ludovica

Volltext

What is the risk of intracranial bleeding during anti-VEGF therapy? von Carden, Craig P, Larkin, James M G, Rosenthal, Mark A

Volltext

Tyrosine Kinase Inhibitors in the Treatment of Advanced Renal Cell Carcinoma: Focus on Pazopanib von Vasudev, Naveen S., Larkin, James M.G.

Volltext

Metastatic renal mucinous tubular and spindle cell carcinoma. Atypical behavior of a rare, morphologically bland tumor von Thway, Khin, FRCPath, du Parcq, John, FRCPath, Larkin, James M.G., MRCP, PhD, Fisher, Cyril, MD, DSc, FRCPath, Livni, Naomi, FRCPath

Volltext

Prognostic and predictive markers in metastatic renal cell carcinoma von Khattak, Muhammad A, Bakr, Farrah, Krzystanek, Marcin, Szallasi, Zoltan, Gerlinger, Marco, Santos, Claudio, Swanton, Charles, Pickering, Lisa M, Gore, Martin E, Larkin, James M G

Volltext